While FDA has performed acceptance and submitting evaluations of numerous PMTAs, it continues to be getting knowledge in applying the statutory authorization typical to PMTAs mainly because several have contained enough facts to achieve substantive assessment. The key target with the proposed rule's content material prerequisites is the brink quant